Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers (Correct) - Bloomberg (Www.OSIR.org.in)
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to
Source: www.bloomberg.com
Genzyme, Osiris ink $1B deal - Boston Business Journal
Genzyme Corp. has signed an alliance with stem cell company Osiris Therapeutics to develop two new treatments. Assuming the drugs reach the marketplace, the arrangement could cost Genzyme up to $1.25 billion in development, regulatory and sales
Source: boston.bizjournals.com